Literature DB >> 3130610

The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene.

A Riccio1, L R Lund, R Sartorio, A Lania, P A Andreasen, K Danø, F Blasi.   

Abstract

The human gene for plasminogen activator inhibitor type-1 (PAI-1) has been isolated and its promoter region characterized. PAI-1 regulation by glucocorticoids, transforming growth factor-beta (TGF-beta) and the phorbol ester PMA is shown to be exerted at the promoter level. A fragment spanning 805 nucleotides of the 5' flanking and 72 of the 5' untranslated region contain information enough to promote transcription and to respond to glucocorticoids when fused to a reporter gene and transfected into human fibrosarcoma cells. A moderately repetitive DNA sequence, containing a TATA box, a GRE consensus, a Z-DNA forming sequence and two imperfect direct repeats at the extremities, is present a few nucleotides 5' of the human PAI-1 gene transcription start site, raising the possibility that this gene could have been activated by DNA insertion during evolution.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3130610      PMCID: PMC336434          DOI: 10.1093/nar/16.7.2805

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  62 in total

1.  Sequence analysis of a KpnI family member near the 3' end of human beta-globin gene.

Authors:  M Hattori; S Hidaka; Y Sakaki
Journal:  Nucleic Acids Res       Date:  1985-11-11       Impact factor: 16.971

2.  Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity.

Authors:  E B Leof; J A Proper; A S Goustin; G D Shipley; P E DiCorleto; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

3.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix.

Authors:  R A Ignotz; J Massagué
Journal:  J Biol Chem       Date:  1986-03-25       Impact factor: 5.157

4.  Characterization of the dexamethasone-induced inhibitor of plasminogen activator in HTC hepatoma cells.

Authors:  P L Coleman; P D Patel; B J Cwikel; U M Rafferty; R Sznycer-Laszuk; T D Gelehrter
Journal:  J Biol Chem       Date:  1986-03-25       Impact factor: 5.157

5.  Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification.

Authors:  L S Nielsen; P A Andreasen; J Grøndahl-Hansen; J Y Huang; P Kristensen; K Danø
Journal:  Thromb Haemost       Date:  1986-04-30       Impact factor: 5.249

Review 6.  Steroid receptor regulated transcription of specific genes and gene networks.

Authors:  K R Yamamoto
Journal:  Annu Rev Genet       Date:  1985       Impact factor: 16.830

7.  Plasminogen activator inhibitor type 1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cells.

Authors:  P A Andreasen; C Pyke; A Riccio; P Kristensen; L S Nielsen; L R Lund; F Blasi; K Danø
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

8.  The human urokinase-plasminogen activator gene and its promoter.

Authors:  A Riccio; G Grimaldi; P Verde; G Sebastio; S Boast; F Blasi
Journal:  Nucleic Acids Res       Date:  1985-04-25       Impact factor: 16.971

9.  Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.

Authors:  P A Andreasen; T H Christensen; J Y Huang; L S Nielsen; E L Wilson; K Danø
Journal:  Mol Cell Endocrinol       Date:  1986-05       Impact factor: 4.102

10.  Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor.

Authors:  R L Nachman; K A Hajjar; R L Silverstein; C A Dinarello
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

View more
  13 in total

1.  Transforming growth factor-ßs as modulators of pericellular proteolytic events.

Authors:  J Keski-Oja; J Lohi; M Laiho
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

2.  Plasminogen activator inhibitor-type 1 in Lewis lung carcinoma.

Authors:  P Kristensen; C Pyke; L R Lund; P A Andreasen; K Danø
Journal:  Histochemistry       Date:  1990

3.  Pocket protein-independent repression of urokinase-type plasminogen activator and plasminogen activator inhibitor 1 gene expression by E2F1.

Authors:  M Koziczak; W Krek; Y Nagamine
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

4.  Transcriptional regulation of plasminogen activator inhibitor type-1 mRNA in Hep G2 cells by epidermal growth factor.

Authors:  W E Hopkins; D R Westerhausen; B E Sobel; J J Billadello
Journal:  Nucleic Acids Res       Date:  1991-01-11       Impact factor: 16.971

5.  Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53.

Authors:  C Kunz; S Pebler; J Otte; D von der Ahe
Journal:  Nucleic Acids Res       Date:  1995-09-25       Impact factor: 16.971

6.  Transforming growth factor beta 1-responsive element: closely associated binding sites for USF and CCAAT-binding transcription factor-nuclear factor I in the type 1 plasminogen activator inhibitor gene.

Authors:  A Riccio; P V Pedone; L R Lund; T Olesen; H S Olsen; P A Andreasen
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

7.  Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation.

Authors:  L Pertovaara; L Sistonen; T J Bos; P K Vogt; J Keski-Oja; K Alitalo
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

8.  Molecular organization of the rat glia-derived nexin/protease nexin-1 promoter.

Authors:  H Ernø; D Monard
Journal:  Gene Expr       Date:  1993

9.  The TGF-beta1/upstream stimulatory factor-regulated PAI-1 gene: potential involvement and a therapeutic target in Alzheimer's disease.

Authors:  Paul J Higgins
Journal:  J Biomed Biotechnol       Date:  2006

10.  Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells.

Authors:  L R Lund; J Rømer; E Rønne; V Ellis; F Blasi; K Danø
Journal:  EMBO J       Date:  1991-11       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.